ELDN
Eledon Pharmaceuticals, Inc.
-0.01 (-0.47%)2.66USD186K成交股數216M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-13下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 18.2M | 17.2M | 17.5M | 15.0M | 20.3M | 13.5M | 16.5M | 10.1M | 7.4M | 7.1M | 7.9M | 7.2M |
| 銷售管理費用 | 4.6M | 4.0M | 4.0M | 4.1M | 4.5M | 4.4M | 4.0M | 4.4M | 3.5M | 3.3M | 3.3M | 3.2M |
| 營業利益 | −22.9M-8% | −21.2M+18% | – | −19.1M+31% | −24.7M+128% | −18.0M+74% | −20.5M+83% | −14.5M+40% | −10.9M | −10.3M | −11.2M | −10.4M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −31.6M+182% | −39.0M+501% | −10.4M-114% | −17.5M-61% | −11.2M-53% | −6.5M-78% | 77.0M-877% | −44.9M-32% | −23.6M | −30.1M | −9.9M | −65.8M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.27+108% | -0.33+313% | -0.10-64% | -0.21-77% | -0.13-80% | -0.08-91% | -0.28-15% | -0.92-66% | -0.65 | -0.91 | -0.33 | -2.74 |
| 稀釋股數 | 114M | 112M | 81.8M | 77.2M | 77.2M | 77.1M | 55.5M | 42.3M | 30.0M | 24.6M | 30.0M | 24.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 6.8M | 6.2M | 22.8M | 3.7M | 5.7M | 8.5M | 6.8M | 26.0M | 5.7M | 4.6M | 3.7M | 40.9M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 126M | 147M | 169M | 130M | 145M | 161M | 115M | 120M | 80.8M | 89.1M | 96.1M | 107M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 54.1M | 46.2M | 32.2M | 38.8M | 38.9M | 46.7M | 38.5M | 129M | 95.5M | 81.9M | 60.5M | 63.0M |
| 股東權益 | 33.0M | 44.8M | 81.1M | 35.4M | 50.3M | 58.9M | 20.4M | −64.2M | −70.4M | −48.5M | 35.6M | 43.8M |
| 負債比 | 42.9% | 31.5% | 19.1% | 29.9% | 26.8% | 29.0% | 33.6% | 107.1% | 118.2% | 91.9% | 62.9% | 59.0% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −22.6M+41% | – | – | – | −16.1M | – | – | −8.7M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −45.6M | –% | -0.52 | – |
| FY2024 | – | – | −36.2M | –% | -0.66 | – |
| FY2023 | – | – | −117M | –% | -4.73 | – |
| FY2022 | – | – | −88.0M | –% | -6.16 | – |
| FY2021 | – | – | −34.5M | –% | -2.33 | – |
| FY2020 | – | – | −22.8M | –% | -15.72 | – |
| FY2019 | – | – | −16.0M | –% | -24.42 | – |
| FY2018 | – | – | −14.1M | –% | -1.56 | – |